1. Home
  2. NRXP vs SGRP Comparison

NRXP vs SGRP Comparison

Compare NRXP & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SGRP
  • Stock Information
  • Founded
  • NRXP 2015
  • SGRP 1967
  • Country
  • NRXP United States
  • SGRP United States
  • Employees
  • NRXP N/A
  • SGRP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SGRP Business Services
  • Sector
  • NRXP Health Care
  • SGRP Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • SGRP Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SGRP 24.5M
  • IPO Year
  • NRXP N/A
  • SGRP 1996
  • Fundamental
  • Price
  • NRXP $3.24
  • SGRP $0.93
  • Analyst Decision
  • NRXP Strong Buy
  • SGRP
  • Analyst Count
  • NRXP 4
  • SGRP 0
  • Target Price
  • NRXP $28.50
  • SGRP N/A
  • AVG Volume (30 Days)
  • NRXP 204.8K
  • SGRP 38.6K
  • Earning Date
  • NRXP 08-13-2025
  • SGRP 08-13-2025
  • Dividend Yield
  • NRXP N/A
  • SGRP N/A
  • EPS Growth
  • NRXP N/A
  • SGRP N/A
  • EPS
  • NRXP N/A
  • SGRP N/A
  • Revenue
  • NRXP N/A
  • SGRP $196,814,000.00
  • Revenue This Year
  • NRXP N/A
  • SGRP N/A
  • Revenue Next Year
  • NRXP N/A
  • SGRP N/A
  • P/E Ratio
  • NRXP N/A
  • SGRP N/A
  • Revenue Growth
  • NRXP N/A
  • SGRP N/A
  • 52 Week Low
  • NRXP $1.10
  • SGRP $0.91
  • 52 Week High
  • NRXP $6.01
  • SGRP $2.48
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.62
  • SGRP 37.72
  • Support Level
  • NRXP $2.90
  • SGRP $0.95
  • Resistance Level
  • NRXP $3.53
  • SGRP $1.01
  • Average True Range (ATR)
  • NRXP 0.20
  • SGRP 0.04
  • MACD
  • NRXP -0.04
  • SGRP -0.01
  • Stochastic Oscillator
  • NRXP 58.73
  • SGRP 23.53

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

Share on Social Networks: